terameprocol has been researched along with B16 Melanoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amin, S; Anderson, KC; Avet-Loiseau, H; Fulciniti, M; Hideshima, T; Li, C; Minvielle, S; Munshi, NC; Nanjappa, P; Prabhala, R; Rodig, S; Tai, YT; Tassone, P | 1 |
Dorr, RT; Lambert, JD; Meyers, RO; Timmermann, BN | 1 |
2 other study(ies) available for terameprocol and B16 Melanoma
Article | Year |
---|---|
Significant biological role of sp1 transactivation in multiple myeloma.
Topics: Animals; Apoptosis; Bone Marrow Cells; Cell Cycle; Cell Proliferation; Cell Survival; Gene Knockdown Techniques; Humans; Male; Masoprocol; Melanoma, Experimental; Mice; Mice, SCID; Multiple Myeloma; RNA Interference; Sp1 Transcription Factor; Transcriptional Activation; Tumor Cells, Cultured | 2011 |
tetra-O-methylnordihydroguaiaretic acid inhibits melanoma in vivo.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Cycle; Colonic Neoplasms; DNA Replication; Female; Intracellular Membranes; Kidney; Liver; Lung Neoplasms; Male; Masoprocol; Melanoma; Melanoma, Experimental; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, SCID; Mitochondria; Neoplasm Transplantation; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |